Free Trial

AstraZeneca (AZN) SEC Filings & 10K Form

→ [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad)
Free AZN Stock Alerts
$76.90
-0.14 (-0.18%)
(As of 05/17/2024 ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Recent AstraZeneca SEC Filings

Export to Excel
DateFilerForm TypeView
05/16/2024
5:41 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2024
9:09 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2024
6:31 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/02/2024
5:49 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
6:18 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/29/2024
5:52 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/25/2024
5:26 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2024
12:22 PM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2024
5:55 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
5:14 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
5:14 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/05/2024
5:22 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2024
7:45 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2024
6:54 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/25/2024
6:28 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/19/2024
4:27 PM		AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Fusion Pharmaceuticals Inc. (Subject)
Form DFAN14A
03/19/2024
3:31 PM		AstraZeneca Finance LLC (Filer)
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form F-3ASR
03/19/2024
5:02 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/14/2024
6:12 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/12/2024
6:29 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2024
5:30 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/07/2024
5:34 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2024
9:06 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2024
9:11 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2024
6:21 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form CERT
03/05/2024
3:40 PM		AstraZeneca Finance LLC (Filer)
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 8-A12B
03/04/2024
5:33 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/01/2024
9:39 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/26/2024
5:19 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/22/2024
8:14 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/22/2024
8:19 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/22/2024
5:08 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/21/2024
7:32 AM		AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
Form SC TO-T/A
02/21/2024
7:13 AM		AstraZeneca Finance LLC (Filer)
AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 424B2
Transaction specifc information for a delayed shelf offering
02/21/2024
5:04 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
8:25 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
6:51 AM		AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
Form SC TO-T/A
02/20/2024
6:49 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
6:12 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
5:52 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
5:47 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
A once-in-a-century investment opportunity (Ad)

It's an under-the-radar stock reshaping a projected $109 billion industry - And, I believe, has far more potential than the AI stocks most investors are focused on in the days ahead.

To get its name and ticker symbol for free - just click here.
02/20/2024
5:27 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/12/2024
9:13 AM		ADC Therapeutics SA (Subject)
AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Form SC 13G/A
02/08/2024
5:40 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/01/2024
9:30 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/24/2024
4:23 PM		AstraZeneca (Subject)
ASTRAZENECA PLC (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
01/19/2024
7:46 AM		AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
Form SC TO-T/A
01/19/2024
7:31 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/10/2024
7:39 PM		AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
Form SC TO-T/A
01/02/2024
9:53 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/27/2023
7:03 AM		AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
Form SC TO-T
12/27/2023
6:09 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/26/2023
4:25 PM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/22/2023
5:19 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/14/2023
9:20 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/12/2023
4:15 PM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/12/2023
4:15 PM		AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Icosavax, Inc. (Subject)
Form SC TO-C
12/12/2023
5:26 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/01/2023
10:50 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/01/2023
10:53 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/01/2023
5:26 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/24/2023
6:11 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/17/2023
5:36 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/16/2023
10:16 AM		AstraZeneca (Filed by)
ASTRAZENECA PLC (Filed by)
Cellectis S.A. (Subject)
Form SC 13D/A
11/14/2023
5:39 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/13/2023
7:19 AM		AstraZeneca (Subject)
ASTRAZENECA PLC (Subject)
SARIN ARADHANA (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/09/2023
9:01 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/09/2023
9:05 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/09/2023
8:49 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/09/2023
8:57 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/01/2023
11:24 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/01/2023
5:38 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/03/2023
6:36 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/03/2023
6:36 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/02/2023
9:27 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2023
11:49 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2023
5:55 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/15/2023
10:00 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/11/2023
10:07 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/06/2023
5:59 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/01/2023
9:20 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/01/2023
11:23 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/28/2023
7:46 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/28/2023
5:25 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/17/2023
1:08 PM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/03/2023
12:35 PM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/03/2023
7:30 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/28/2023
4:28 PM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d)  
06/09/2023
5:38 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/09/2023
5:21 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/02/2023
11:12 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Shocking $16T Elon Musk Crypto Leak (Ad)

Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.

Click here now to get your copy.
06/01/2023
11:00 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/01/2023
11:07 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/01/2023
5:36 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/26/2023
5:18 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/25/2023
3:39 PM		AstraZeneca (Subject)
ASTRAZENECA PLC (Subject)
Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
05/22/2023
5:53 AM		AstraZeneca (Filer)
ASTRAZENECA PLC (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies:
SEC Filings Tools:
This page (NASDAQ:AZN) was last updated on 5/18/2024 by MarketBeat.com Staff

From Our Partners
Shocking $16T Elon Musk Crypto Leak
Crypto 101 Media
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
Make this ONE trade on Tuesday at 2 p.m. EST!
Monument Traders Alliance
The Presidential candidate you should REALLY be worried about
Stansberry Research
Protect Your Bank Account Before It’s Too Late
Weiss Ratings
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
What’s Really Next for America…
Porter & Company
He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”
InvestorPlace